5/1/2023 0 Comments Akila viswanathan![]() Using radiation and paclitaxel-platinum chemotherapy should be attempted whenever feasible for patients with UPSC who do not have distant metastases at diagnosis.Ĭopyright © 2011 Elsevier Inc. Join Facebook to connect with Akila Viswanathan and others you may know. ![]() RFS was improved by radiation and chemotherapy with few grade 3 or higher complications. Akila Visvanathan John Tallach Murchison Richard Brady Medical smartphone applications are increasingly popular amongst doctors. Uterine papillary serous cancer can be an aggressive tumor type with a poor prognosis. The 5-year grade 3+ toxicity rate was 3.5% for those who received RT and was 2.9% for those who did not (p=NS). RFS was improved for patients treated with RT (HR=0.44, 95% CI 0.25-0.77, p=0.004). Listen to On Target with Dr Akila Viswanathan - Breast Cancer in the Modern Era for Seminars in Radiation Oncology MP3 Song by Akila Viswanathan from the album Johns Hopkins Kimmel Cancer Center Podcasts - season - 1 free online on Gaana. Today, the Johns Hopkins University School of Medicine has more than 250 tenured female faculty members, including t recently named professor Akila Viswanathan, M.D., M.P.H., M.Sc., professor of radiation oncology and molecular radiation sciences. Dr Akila Viswanathan, Baltimore, Maryland. The 1780640458 NPI number is assigned to the healthcare provider AKILA VISWANATHAN MD MPH, practice location. A paclitaxel-platinum chemotherapy regimen was significantly associated with longer OS (hazard ratio =0.34, 95% confidence interval 0.15-0.74, p=0.007) and RFS (HR=0.45, 95% CI 0.22-0.92, p=0.03). This webpage represents 1780640458 NPI record. On Cox regression analysis, increasing age, stage, and myometrial invasion were prognostic factors associated with shorter OS and RFS. Median 5-year OS was 52%, and RFS was 42% for all patients. Viswanathan sees patients at the Johns Hopkins Hospital and at the Kimmel Cancer Center at Sibley Memorial Hospital. Patient, tumor, treatment and relapse characteristics of 135 women with Stages I-IVA UPSC treated between 19 at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) were analyzed using Cox regression models to determine prognostic and predictive factors for OS, RFS and toxicity. Akila Viswanathan, M.D., M.P.H., is the director for Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, the director for the National Capital Region for radiation oncology, and a professor of radiation oncology and molecular radiation sciences for Johns Hopkins University School of Medicine. To identify prognostic and predictive factors of overall survival (OS), relapse-free survival (RFS) and toxicity for patients with uterine papillary serous carcinoma (UPSC). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |